(ENTA)—ABBV 4Q20 Mavyret sales=$481M, +16% QoQ, -23% YoY: https://news.abbvie.com/news/press-releases/abbvie-reports-full-year-and-fourth-quarter-2020-financial-results.htm The $481M consisted of: $420M US; $461M ex-US. Mavyret full-year 2020 sales were $1.83B, slightly below ABBV’s most recent guidance of $1.9B.